Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use

Journal of Clinical Pharmacology - Tập 45 Số 12 - Trang 1345-1359 - 2005
Limin Zhou1, Zhong Zuo1, Moses S. S. Chow1
1School of Pharmacy and Drug Development Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, PRC

Tóm tắt

Danshen, the dried root of Salvia miltiorrhiza, has been widely used in China and, to a lesser extent, in Japan, the United States, and other European countries for the treatment of cardiovascular and cerebrovascular diseases. In China, the specific clinical use is angina pectoris, hyperlipidemia, and acute ischemic stroke. The current review covers its traditional uses, chemical constituents, pharmacological activities, pharmacokinetics, clinical applications, and potential herb‐drug interactions based on information obtained in both the English and Chinese literature. Although numerous clinical trials have demonstrated that certain Danshen products in China are effective and safe for the treatment of cardiovascular diseases, most of these lack sufficient quality. Therefore, large randomized clinical trials and further scientific research to determine its mechanism of actions will be necessary to ensure the safety, effectiveness, and better understanding of its action.

Từ khóa


Tài liệu tham khảo

Ma JY., 1998, Clinical observation of the treatment of hyperlipemia with Danshen composite, Tianjin Zhongyi, 15, 24

Wu XY, 2000, Clinical observation of the treatment of 60 hyperlipaemia with Fufang Danshen Dripping Pill, Hebei Zhongyi, 22, 671

Ma WY, 2001, Effect of Danshen composite on hyperlipaemia and blood rheology, Jiefangjun Yaoxue Xuebao, 17, 47

Cui SK, 2003, Clinical effect of Fufang Danshen Dripping Pill on hyperlipemia, Xiandai Zhongxiyi Jiehe Zazhi, 11, 1029

Mao JM, 2001, Clinical observation of Danshen composite on cerebral infarction, Jiefangjun Yaoxue Xuebao, 17, 49

Guo ZX, 2003, Clinical investigation of composite Danshen Dripping Pill for the treatment of angina pectoris, Zhongguo Tianran Yaowu, 1, 124

Liu XQ, 2001, Research advance of Fufang Danshen dosage forms, Shizhen Guoyi Guoyao, 12, 474

Hu XR, 2003, An investigation of Danshen root: pharmacology study, clinical application and preparation, Zhongguo Xinyiyao, 2, 54

Ge YR, 2002, Review of research on pharmacopoeia prescription preparation of compound salvia, Zhong Cheng Yao, 24, 872

Hu RF, 2002, Study on tanshinone rapid soluble tablet, Zhongguo Yaoshi, 5, 461

Chu MQ, 2002, Study on the preparation of tanshinone preliposomes by spray drying method, Zhongguo Yaoxue Zazhi, 37, 32

Chu MQ, 2001, Study on solid dispersion of tanshinone, Huadong Ligong Daxue Xuebao, 27, 191

The Pharmacopoeia Commission of PRC., 2005, Pharmacopoeia of the People's Republic of China Version 2005

Tianjin Talisco Pharmaceutical Group Co. Ltd.Approval of Compound Danshen Dripping Pill (DSP) by FDA through pre‐IND for clinical trials.Proceedings of Forum of Internationalized Chinese Materia Medica.1998:18–30.

Kong DY., 1989, Chemical constituents of Salvia miltiorrhiza (Danshen), Zhongguo Yiyao Gongye Zazhi, 20, 279

Zheng GH, 1989, Research on chemical constituents of Danshen, Zhongguo Yaoxue Zazhi, 24, 6

Cai DG., 1991, Advances in the study of chemical constituents of Danshen, Zhongguo Zhongyao Zazhi, 16, 376

Li LN., 1997, Water soluble active components of Salvia miltiorrhiza and related plants, Zhongguo Yaoxue, 6, 57

Dong ZT, 1982, Effect of danshensu on isolated swine coronary artery perfusion preparation, YaoxueXuebao, 17, 226

Li CZ, 1983, Anticoagulant studies of Danshen, Zhongxiyi Jiehe Zazhi, 3, 297

Cheng ZH, 1987, Studies on effects of “danshensu” on experimental microcirculatory disturbances and plasma lactic acid concentrations, Shanghai Yike Daxue Xuebao, 14, 25

Tang LH, 1989, The protection of DS‐182 during reperfusion of total ischemia heart, Zhongguo Bingli Shengli Zazhi, 5, 65

10.1016/S0024-3205(03)00142-5

Su XH, 1992, The effect of danshensu (DS‐182) of the injury of oxygen free radicals in myocardial mitochondria from rat myocardium, Zhongguo Bingli Shengli Zazhi, 8, 122

Zhao BL, 1996, Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia‐reperfusion injury, Biochem Mol Biol Int, 38, 1171

10.1016/j.lfs.2004.06.010

Chen YH, 2000, Salvianolic acid B protects brain against injuries caused by ischemia‐reperfusion in rats, Zhongguo Xinyao Zazhi, 21, 463

Li M, 2004, Inhibition of shear‐induced platelet aggregation in rat by tetramethylpyrazine and salvianolic acid B, Clin Hemorheol Microcirc, 31, 97

10.1016/S0024-3205(00)00989-9

10.1161/01.ATV.18.3.481

10.1023/A:1007081911734

10.1254/jjp.87.289

10.1016/S0006-2952(01)00686-4

10.1016/j.lfs.2004.02.034

10.1016/0006-2952(93)90624-6

10.1080/10715760000301471

10.1016/S0006-2952(02)01250-9

Zhuang YL, 1999, HPLC determination of danshensu and protocatechuic aldehyde in rat plasma, Yaoxue Xuebao, 34, 613

Hong X, 2000, Pharmacokinetics study of danshensu in compound Danshen Dripping Pill, Zhongyao Xinyao yu Linchuang Yaoli, 11, 286

Pan GX, 2003, Determination of danshensu in rat serum after oral administer compound Salvia Recipe, Zhongguo Zhongyao Zazhi, 28, 562

10.1093/chromsci/41.6.327

He HB, 1983, Determination of danshensu and its pharmacokinetic parameter in rabbit by fluorometry, Shanghai Diyi Yixueyuan Xuebao, 10, 295

10.1248/bpb.20.285

10.1002/bmc.105

Zhao XF, 2004, Qualitative and quantitative analysis of compound Danshen Dripping Pills by CS‐HPLC, Zhong Cheng Yao, 26, 490

Pei WJ, 2004, Study of the determination and pharmacokinetics of compound Danshen Dripping Pill in human serum by column switching liquid chromatography electrospray ion trap mass spectrometry, J Chromotogr B, 809, 237, 10.1016/S1570-0232(04)00512-4

Liu Q, 2003, Determination of danshensu in urine and its pharmacokinetics in human, Yaoxue Xuebao, 38, 771

Wang NS, 2000, LC/MS for the determination of relative ingredients of Radix Salvia Miltiorrhiza in biological sample after oral administration of Danshen Dripping Pill, Zhongyao Xinyao yu Linchuang Yaoli, 11, 141

10.1055/s-2004-815490

10.1124/dmd.32.7.752

Li XC, 2004, Pharmacokinetics of magnesium lithospermate B after intravenous administration in beagle dogs, Zhongguo Yaoli Xuebao, 25, 1402

Qiao JP, 2003, Determination of tanshinone IIA in rat plasma and the pharmacokinetics by RP‐HPLC method, Yaoxue Xuebao, 38, 368

Yuan Y, 2002, The absorption mechanism of tanshinone IIA in rat small intestine, Huaxi Yaoxue Zazhi, 17, 246

Pang ZG, 1999, Study on pharmacokinetics of tanshinone IIA in prescription, Xi'an Yike Daxue Xuebao, 20, 457

Xue M, 1999, Pharmacokinetics of cryptotanshinone and its metabolite in pigs, Yaoxue Xuebao, 34, 81

Xie MZ, 1983, Absorption, distribution, excretion and metabolism of cryptotanshinone, Yaoxue Xuebao, 18, 90

10.1016/0197-2456(95)00134-4

Ding XM, 1999, Curative effect of Danshen composite on stable angina pectoris, Zhongguo Linchuang Yixue, 6, 21

He YZ., 2004, Treatment with Danshen composite of 40 patients with coronary heart disease and angina, Linchuang Shijian, 22, 107

Wang XY, 1999, Comparison of Danshen composite and isosorbide dinitrate in the treatment of angina pectoris and coronary heart disease, Jizhen Yixue, 8, 395

Peng FQ., 2003, Clinical observation of Danshen composite in the treatment of coronary heart disease and angina, Xiandai Zhongxiyi Jiehe Zazhi, 12, 1377

Xu XM., 2000, Clinical effect of Danshen composite on 160 patients with angina pectoris, Zhongcaoyao, 31, 44

Deng GH, 2002, Clinical effect of Danshen composite on stable angina pectoris, Tianjin Yaoxue, 14, 48

Wang X., 2001, Clinical effects observation of compound Danshen Dripping Pills in treating unsteady angina pectoris patients, Jiefangjun Yaoxue Xuebao, 17, 78

Sun L, 2000, Clinical effect of composite Danshen Dripping Pill on 40 patients with coronary heart disease and angina pectoris, Tianjin Zhongyi, 17, 6

Xiang NZ, 2004, A observation on the effect of Guttae S. miltiorrhiza to alleviate angina in patients with CHD, Zhongguo Linchuang Baojian Zazhi, 7, 110

WuK XiaXM HuiHS.A comparative study of drug resistance in the treatment of angina with Danshen composite and dinitrosorbide.The National Workshop on the Modernization of Traditional Chinese Medicine (Compound Danshen) 1999.1999:7.

QianTL.Observation of the rapid pain relief on angina pectoris associated with coronary heart disease by composite Danshen Pills.Proceedings to 1996 National Symposium on Composite Danshen Pharmaceuticals.1996:36.

Wang YY, 2004, Comparison of dissolving compound Salvia miltiorrhiza in mouth and dissolving nitroglycerin in mouth to treat angina pectoris, Henan Zhigong Yixueyuan Xuebao, 16, 227

Sun D, 2003, Clinical effect observation of composite Danshen Dripping Pill on coronary heart disease and angina, Qingdao Yiyao Weisheng, 35, 281

Shen HQ, 2003, Clinical effect comparison of composite Danshen Dripping Pill and Danshen tablet on coronary heart disease and angina pectoris, Shiyong Zhongxiyi Jihe Linchuang, 3, 7

Jia LW, 2000, Comparison of clinical effect of composite Danshen Dripping Pill with Fufang Danshen Tablet in patients with coronary heart disease and angina, Zhongguo Zhongyi Jizheng, 9, 106

Zhou JZ, 2003, Clinical observation of composite Danshen dripping pill on 100 patients with coronary heart disease, Linchuang Yiyao Shijian Zazhi, 12, 264

Zheng HB., 2000, The therapeutic effect of compound radices Salvia miltiorrhiza drop‐Pilulae on angina of coronary heart disease: a randomized controlled clinical trial, Jibing Kongzhi Zazhi, 4, 284

Lin P, 2001, Clinical effect comparison of composite Danshen Dripping Pill on angina pectoris, Guangzhou Yiyao, 32, 73

Guan ZX, 2000, Curative effect of composite Salvia miltiorrhiza bunge complex aerosol on ischemic angina pectoris, Zhongguo Zhongxiyi Jiehe Jijiu Zazh, 7, 69

Tan JQ, 2000, Clinical research of Fufang Danshen Aerosol on coronary heart disease and angina, Guangdong Yaoxue, 10, 42

Wang YY., 2002, Clinical observation of Salvia miltiorrhiza injection in treatment of coronary heart disease with angina pectoris, Zhongguo Zhongxiyi Jiehe Jijiu Zazhi, 9, 307

Shao M., 2003, Clinical effect of Danshen Injection on unstable angina pectoris, Anhui Zhongyi Xueyuan Xuebao, 22, 13

Jiang D., 2003, Clinical effect of Danshen Injection on coronary heart disease, angina and effect on platelet aggregation, Zhongguo Zhongyi Jizheng, 12, 105

Shi YH., 1997, Control study of Fufang Danshen Dripping Pill and isosorbide dinitrite on stable angina pectoris, Zhongguo Zhongxiyi Jiehe Zazhi, 17, 23

Wang ZQ, 2002, Evaluation of therapeutic effect of compound Danshen Dripping Pill on coronary heart disease using movement ECG, Helongjiang Yiyao Kexue, 25, 9

Pan WY., 2002, Evaluation of exercise ECG of Fufang Danshen Dripping Pill and isosorbide dinitrite on stable angina pectoris and the metabolic effect on lipid, Shijie Yixue Zazhi, 6, 55

Li XL, 2003, Evaluation of therapeutic effect of compound Danshen Dripping Pill on stable angina pectoris using movement ECG, Zhongguo Laonianxue Zazhi, 23, 183

10.1002/14651858.CD004295.pub2

10.1111/j.1600-0404.2004.00369.x

Zhang H, 2002, Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza), Zhongguo Xinyao Zazhi, 23, 1163

10.7326/0003-4819-142-12_Part_2-200506211-00003

10.1007/BF03190157

10.1111/j.2042-7158.1995.tb05819.x

10.1345/aph.19029

10.1111/j.1445-5994.1995.tb01540.x

10.1046/j.1365-2796.1997.134137000.x

10.1016/S0003-4975(98)00624-9

10.1002/jcla.10057

Deng H, 1992, Mechanisms of protective actions of radix Salviae miltiorrhizae (RSM) against experimental hepatic injury in rats, Zhongguo Zhongyao Zazhi, 17, 233

10.1211/0022357021602

10.1016/j.lfs.2003.07.035